Tuesday - January 20, 2026

Category Archives: Europe

Green Water Treatment Chemicals Market 2026-2029: Growth Overview, Facts & Figures, Segmentation, Future Trends, and Historical Analysis | Kemira (Finland), Veolia (France), Ecolab (US)

The Green Water Treatment Chemicals Market is gaining traction due to rising environmental regulations, water scarcity concerns, and demand for sustainable treatment solutions. Key players such as BASF SE, Ecolab, Solenis, Kemira, and SUEZ are focusing on bio-based, low-toxicity chemicals … Continue reading →

Autoimmune Encephalitis Market Size in the 7MM is expected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Autoimmune Encephalitis Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Autoimmune Encephalitis, historical and forecasted epidemiology as well as the Autoimmune Encephalitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and … Continue reading →

Herpes Zoster Market Size in the 7MM is projected to increase at a significantly CAGR by 2034, estimates DelveInsight

DelveInsight’s “Herpes Zoster Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of the Herpes Zoster, historical and forecasted epidemiology as well as the Herpes Zoster market trends in the United States, EU5 (Germany, Spain, Italy, France, and … Continue reading →

Hemophilia A Clinical Trial Pipeline Shows Potential with Active Contributions from 40+ Key Companies | DelveInsight

DelveInsight’s, “Hemophilia A Pipeline Insights 2026” report provides comprehensive insights about 40+ companies and 40+ pipeline drugs in the Hemophilia A pipeline landscape. It covers the Hemophilia A pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Malignant Ascites Clinical Trial Pipeline Accelerates as 5+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Malignant Ascites Pipeline Insights 2026” Report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Malignant Ascites pipeline landscape. It covers the Malignant Ascites pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Steroid Refractory Acute GvHD Clinical Trial Pipeline Gains Momentum: 3+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Steroid Refractory Acute Graft Versus Host Disease Pipeline Insights 2026” Report provides comprehensive insights about 3+ companies and 4+ pipeline drugs in Steroid Refractory Acute Graft Versus Host Disease pipeline landscape. It covers the Steroid Refractory Acute Graft Versus … Continue reading →

Myopia Treatment Pipeline Shows Strong Momentum as 8+ Pharma Companies in the Race | DelveInsight

DelveInsight’s “Myopia Pipeline Insight 2026” report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in the Myopia pipeline landscape. It covers the Myopia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Myopia pipeline … Continue reading →